Panda Suchita, El khader Ismail, Casellas Francesc, López Vivancos Josefa, García Cors Montserrat, Santiago Alba, Cuenca Silvia, Guarner Francisco, Manichanh Chaysavanh
Digestive System Research Unit, Vall d'Hebron Research Institute, Barcelona, Spain.
Digestive System Research Unit, Vall d'Hebron Research Institute, Barcelona, Spain; Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
PLoS One. 2014 Apr 18;9(4):e95476. doi: 10.1371/journal.pone.0095476. eCollection 2014.
From birth onwards, the human gut microbiota rapidly increases in diversity and reaches an adult-like stage at three years of age. After this age, the composition may fluctuate in response to external factors such as antibiotics. Previous studies have shown that resilience is not complete months after cessation of the antibiotic intake. However, little is known about the short-term effects of antibiotic intake on the gut microbial community. Here we examined the load and composition of the fecal microbiota immediately after treatment in 21 patients, who received broad-spectrum antibiotics such as fluoroquinolones and β-lactams. A fecal sample was collected from all participants before treatment and one week after for microbial load and community composition analyses by quantitative PCR and pyrosequencing of the 16S rRNA gene, respectively. Fluoroquinolones and β-lactams significantly decreased microbial diversity by 25% and reduced the core phylogenetic microbiota from 29 to 12 taxa. However, at the phylum level, these antibiotics increased the Bacteroidetes/Firmicutes ratio (p = 0.0007, FDR = 0.002). At the species level, our findings unexpectedly revealed that both antibiotic types increased the proportion of several unknown taxa belonging to the Bacteroides genus, a Gram-negative group of bacteria (p = 0.0003, FDR<0.016). Furthermore, the average microbial load was affected by the treatment. Indeed, the β-lactams increased it significantly by two-fold (p = 0.04). The maintenance of or possible increase detected in microbial load and the selection of Gram-negative over Gram-positive bacteria breaks the idea generally held about the effect of broad-spectrum antibiotics on gut microbiota.
从出生起,人类肠道微生物群的多样性迅速增加,并在三岁时达到类似成人的阶段。在这个年龄之后,其组成可能会因抗生素等外部因素而波动。先前的研究表明,在停止服用抗生素数月后,恢复力并不完全。然而,关于抗生素摄入对肠道微生物群落的短期影响知之甚少。在这里,我们检查了21名接受氟喹诺酮类和β-内酰胺类等广谱抗生素治疗的患者治疗后立即的粪便微生物群负荷和组成。在治疗前和治疗后一周从所有参与者收集粪便样本,分别通过定量PCR和16S rRNA基因焦磷酸测序进行微生物负荷和群落组成分析。氟喹诺酮类和β-内酰胺类显著降低了微生物多样性25%,并将核心系统发育微生物群从29个分类单元减少到12个。然而,在门水平上,这些抗生素增加了拟杆菌门/厚壁菌门的比例(p = 0.0007,FDR = 0.002)。在物种水平上,我们的研究结果意外地发现,两种抗生素类型都增加了属于拟杆菌属的几种未知分类单元的比例,拟杆菌属是一组革兰氏阴性细菌(p = 0.0003,FDR<0.016)。此外,平均微生物负荷受到治疗的影响。事实上,β-内酰胺类使其显著增加了两倍(p = 0.04)。微生物负荷的维持或可能增加以及革兰氏阴性菌相对于革兰氏阳性菌的选择打破了人们普遍认为的广谱抗生素对肠道微生物群影响的观念。